Viewing data from:

CEFAZOLIN SODIUM

ANDA

CEFAZOLIN SODIUM | A062688 | ABRAXIS PHARMACEUTICAL PRODUCTS

4 strengths0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Cefazolin Sodium (2023)

Total Spending

$95K

Total Claims

23,554

Beneficiaries

16,174

ASP Price

$0.77

YoY Change:-11.9%

5yr CAGR:-0.6%

HCPCS: J0690 — Injection, cefazolin sodium, 500 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain3 active DMFs11 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

ACS DOBFAR SPACEFAZOLIN SODIUM LYOPHILIZED (STERILE, BULK)

DMF 132081998

SANDOZ GMBHCEFAZOLIN SODIUM (STERILE)

DMF 141331999

ORCHID PHARMA LTDCEFAZOLIN USP

DMF 150222000

HOECHST AGInactiveCEFAZOLIN SODIUM INJECTION (STERILE FILLING)

DMF 67841987

GEMA SAInactiveCEFAZOLIN

DMF 81371989

BIOCHEMIC GESELLSCHAFT MBHInactiveCEFAZOLIN

DMF 86341990

ASTELLAS PHARMA INCInactiveCEFAZOLIN

DMF 101561991

ACS DOBFAR SPAInactiveCEFAZOLIN SODIUM

DMF 136901998

BRISTOL MYERS SQUIBB COInactiveCEFAZOLIN SODIUM

DMF 137071998

TEVA PHARMACEUTICALS USA INCInactiveCEFAZOLIN SODIUM

DMF 137411998

BRISTOL MYERS SQUIBB COInactiveCEFAZOLIN SODIUM

DMF 137501998

ASTELLAS PHARMA INCInactiveCEFAZOLIN SODIUM (STERILE)

DMF 137971998

AUROBINDO PHARMA LTDInactiveCEFAZOLIN SODIUM USP

DMF 183862005

CSPC ZHONGNUO PHARMACEUTICAL SHIJIAZHUANG CO LTDInactiveCEFAZOLIN SODIUM (STERILE)

DMF 245272011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#002 — EQ 500MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Nov 17, 1986

No patent or exclusivity listings for this strength.

#003 — EQ 1GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Nov 17, 1986

#004 — EQ 10GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Nov 17, 1986

#005 — EQ 20GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Aug 3, 1987